List of E-Posters

Alzheimer's Disease and Dementia
1	Comorbidity variations of depression and Dementia in the elderly M. Beridze, A. Dubenko, V. Korostiy, N. Sofilkanych Department of neurology, neurosurgery and psychiatry, Uzhhorod National University, Ukraine
2	Progressive non fluent aphasia: two different clinical cases I. Buxhelaj^1,2, O. Cibuku^1,2, E. Halili^1,2, J. Kruja^1,2, A Kuqo¹, A. Quka¹ ¹Neurology, UHC MotherTeresa, Albania ²Neuroscience, Faculty of Medicine, University of Medicine, Albania
3	A protein-protein interaction connecting neuroinflammation and neurodegeneration in Alzheimer’s disease F. Cioffi¹, W. Adamski¹, R. Bansal³, K. Broersen¹, J. Parkash³, R. Veerhuis⁴, H. Wienk² ¹Nanobiophysics, MIRA Institute for Biomedical Technology and TEchnical Medicine, Faculty of Science and Technology, Universiteit Twente, The Netherlands ²Department of Chemistry, Bijovet Center for Biomolecular Research, Utrecht Universiteit, The Netherlands ³Biomaterials Science and TEchnology, MIRA Institute for Biomedical Technology and TEchnical Medicine, Faculty of Science and Technology, Universiteit Twente, The Netherlands ⁴Department of Psych9iatry, VU University Medical Center, The Netherlands
4	Eye gaze and aging: the role of working memory and inhibitory control T. Crawford¹, E. Smith¹, D. Berry² ¹Psychology Department, Lancaster University, UK ²Psychology Department, Keele University, UK
5	Is dementia a psychiatric or neurological disease – different angels of the same illness – a psychiatrist’s view A. Dawidowska Psychogeriatry, Waitemata District Health Board, New Zealand
6	Bexarotene and astaxanthin modulate cholesterol and amyloid-beta metabolism in cerebrovascular endothelial cells E. Fanaee-Danesh¹, M. Zandl¹, V. Roca Agujetas², C. de Dios², N. Albrecher¹, C. Tam Amersdorfer¹, C. Chakravarthi Gali¹, A. Chirackal Manavalan¹, Y. Sun¹, A. Kober¹, M. Reiter¹, A. Colell², U. Panzenboeck¹ ¹Institute of Pathophysiology and Immunology, Elham Fanaee-Danesh, Austria ²Institut d'Investigacions Biomèdiques de Barcelona IIBB-CSIC, Vicente Roca Agujetas, Spain
7	Stopping statins in the oldest old with dementia and severe dependency D. Justo, A. Kremer, I. Nachimov, M. Ioffe Geriatrics, Sheba Medical Center, Tel-Hashomer; Sackler School of Medicine, Tel-Aviv University, Israel
8	Neurosyphilis combined with acute anterior thalamic infarction J. Lee¹, H. Rhee², S. Yoon¹, K. Park¹ ¹Neurology, Kyung Hee University Hospital, South Korea ²Neurology, Kyung Hee University Hospital at Gangdong, South Korea
9	Frontal cognitive dysfunction with apraxia of eyelid opening after traumatic brain injury: a slowly progressive delayed complication M.Y. Park, D. Shin, M. Kim Neurology, Yeungnam Medical Center, South Korea
10	Analysis of TOMM40 rs2075650 polymorphism frequency in polish Alzheimer’s disease patients M. Prendecki¹, M. Kowalska¹, J. Kosińska², J. Florczak-Wyspiańska³, J. Ilkowski⁴, M. Stański², W. Kozubski³, J. Dorszewska¹ ¹Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poland ²Students Scientific Neurobiological Association, Poznan University of Medical Sciences, Poland ³Chair and Department of Neurology, Poznan University of Medical Sciences, Poland ⁴Department of Emergency Medicine, Poznan University of Medical Sciences, Poland
11	Preliminary results of screening of the mild cognitive impairment and dementia in Almaty S. Turuspekova, R. Tsoy, B. Demesinova, M. Idrisova Department of Nervous Diseases №1, Kazakh National Medical University named after S.D. Asfendiyarov, Kazakhstan
12	Disrupted cholinergic transmission in mice with Alzheimer’s disease-like tauopathy (AD) but not in mice with frontotemporal lobar degeneration-like tauopathy (FTLD) A. Wysocka, M. Zadrozny, M. Steczkowska, E. Palasz, G. Niewiadomska Laboratory of Preclinical Studies in Neurodegenerative Diseases, Nencki Institute of Experimental Biology, Poland
13	Acute hypoxia induced an imbalanced M1/M2 activation of microglia through NF-κB signaling in Alzheimer’s disease mice and wild-type littermates F. Zhang, R. Zhong, W. Le Center for Clinical Research on Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, China
14	Diagnostic prospects of early Alzheimer’s disease based on blood microRNAs K. Zoltowska¹, S. Nagaraj¹, K. Laskowska-Kaszub¹, K. Debski², J. Wojsiat¹, M. Dabrowski², T. Gabryelewicz³, J. Kuznicki⁴, U. Wojda¹ ¹Neurobiology Center, Laboratory of Preclinical Testing of Higher Standard, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Poland ²Neurobiology Center, Laboratory of Bioinformatics, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Poland ³Department of Neurodegenerative Disorders, Mossakowski Medical Research Center, Poland ⁴Laboratory of Neurodegeneration, International Institute of Molecular and Cell Biology, Poland
Epilepsy
15	Theory of mind deficits in two neuropsychiatric populations: patients with mesial temporal lobe epilepsy and schizophrenia A. Bala¹, Ł. Okruszek², M. Szantroch³, A. Rysz³, A. Marchel³ ¹Faculty of Psychology, University of Warsaw, Poland ²Institute of Psychology, Polish Academy of Science, Poland ³Department of Neurosurgery, Medical University of Warsaw, Poland
16	Brain MRI post-processing with map07 in preoperative evaluation of patients with pharmacoresistant epilepsy – our experience A.B. Kovac¹, Z-P. Gadze¹, M. Rados², S. Nankovic¹, V. Sulentic¹, I. Cajic¹, M-K. Skoric¹ ¹Department of Neurology, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Referral Centre of the Ministry of Health of the Republic of Croatia for Epilepsy, Croatia ²Croatian Institute for Brain Research, School of Medicine, University of Zagreb, Croatia
17	Episodic amnesia - vascular or epileptic nature related to mild cognitive impairment A. Cuciureanu², I-D. Cuciureanu¹, T. Cuciureanu^1,3 ¹Neurology, University of medicine “Gr. T. Popa” Iasi, Neurology, Iasi, Romania, Romania ²Neurology, CMI CUCIUREANU ADINA, Romania ³Gastroenterology, University of medicine “Gr. T. Popa” Iasi, Neurology, Iasi, Romania, Romania
18	Prospects for the use of cannabinoids in the treatment of epilepsy S. Czuczwar, B. Miziak Department of Pathophysiology, Medical University of Lublin, Poland
19	Potential benefits of music for patients with epilepsy F. Derke², D. Milat¹, L. Filipovic-Grcic², Z. Petelin-Gadze³ ¹“Sveti Rok”, Polyclinic, Croatia ²School of Medicine, University of Zagreb, Croatia ³Department of Neurology, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Referral Centre of the Ministry of Health of the Republic of Croatia for Epilepsy, Croatia
20	Are the physical anthropological types associated with a presence of epilepsy? A. Dubenko, A. Kutikov Epilepsy department, “Institute of Neurology, Psychiatry and Narcology of the NAMS of Ukraine”, Ukraine
21	The role of serum prolactin in diagnosis of seizure disorders in children M. Elsied, A. Soliman, T. Goda, N. Elawdy Neurology Dep. Zagazig university Faculty of Medicine, Magdy Abdelhamed Aidaros Elsied, Egypt
22	Doctor patient relationship and the art of communication S. Horowitz Yorktown Science Program, Yorktown School, USA
23	Arterial spin labelling in focal epilepsies S. Jaiswal, S. Parida, JMK. Murthy Neurology, Care Institute of Medical Sciences, India
24	Focal nonconvulsive status epilepticus manifested as an antegrade amnesia D.Y. Kim, J. M. Kim Department of Neurology, Chungnam National University School of Medicine, South Korea
25	Cognitive disorders associated with epilepsy screening by Addenbrooke’s Cognitive Examination — revised V. Korostiy¹, A. Dubenko², T. Litovchenko³, I. Blazhina¹ ¹Psychiatry, narcology and medical psychology, Kharkiv National Medical University, Ukraine ²Department of Brain Vascular Pathology, Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine, Ukraine ³Neurology and Child Neurology, Kharkiv Medical Academy of Postgraduate Education, Ukraine
26	Antiepileptic treatment in patients with and without cardiovascular pathology T. Litovchenko², V. Grymailo¹ ¹Functional diagnostic, Kharkiv clinical railway hospital №1, Ukraine ²Neurology and Childhood Neurology, Kharkiv Medical Academy of Postgraduate Education, Ukraine
27	Some aspects of difficulty in the management of status epilepticus in patients with coma T. Manjgaladze³, I. Rukhadze¹, G. Kilptari², M. Mgaloblishvili¹, G. Chakhava⁴ ¹Neurology, Central university clinic after academic N. Kipshidze, Georgia ²Reanimatology, Central university clinic after academic N. Kipshidze, Georgia ³Neurology, LTD "Deka", Georgia ⁴Neurology, Multi profile clinic "Medula", Georgia
28	Cases of frontal epilepsy, revealed during EEG screening in a psychiatric consultation O. Mostovaya Neuropsychiatry, Vinnytsia National Medical University named N. I. Pirogov, Ukraine
29	Functional and structural differences between right - and left - unilateral mesial temporal lobe epilepsies H. Park, J. W. Yang, S. I. Hwang Neurology, Gachon University Gil Medical School, South Korea
30	Super-refractory status epilepticus of unknown etiology with late onset and fatal outcome. Case report V. Sapira¹, M. Lungu², A. Trifan³, I.M. Cojocaru⁴, G. Socoliuc⁵, A. Telehuz⁶ ¹Neurology, Emergency Clinical County Hospital Sf. Apostol Andrei, Romania ²Neurology, Emergency Clinical County Hospital Sf. Apostol Andrei, Romania ³Emergency Department, Emergency Clinical County Hospital Sf. Apostol Andrei, Romania ⁴Neurology, Colentina Clinical Hospital, Romania ⁵Neurology, Sanador Medical Center, Romania ⁶Emergency Department, Emergency County Hospital, Romania
31	Analysis of SCN1A and SCN2A gene polymorphisms in epilepsy patients K. Wize¹, U. Łagan-Jędrzejczyk¹, A. Gac², W. Kozubski³, J. Dorszewska¹ ¹Poznan University of Medical Sciences, Laboratory of Neurobiology, Department of Neurology, Poland ²Poznan University of Medical Sciences, Students Scientific Neurobiological Association, Poland ³Poznan University of Medical Sciences, Chair and Department of Neurology, Poland
32	Autistic-like disorders in children with resistant forms of epilepsy caused by “forced EEG normalization” (Landolt`s) syndrome S. Yevtushenko¹, D. Filimonov² ¹Department of Reconstructive Angioneurology and Neurorehabilitation, V.K. Gusak Institute of Urgent and Reparative Surgery, Ukraine ²Department of Experimental Surgery, V.K. Gusak Institute of Urgent and Reparative Surgery, Ukraine
33	Influence of lacosamide, a third-generation antiepileptic drug on neuroprotection and hippocampal cell proliferation in a mouse brain M. Zagaja¹, A. Szewczyk¹, J. Łuszczki^1,2, M. Andres-Mach¹ ¹Isobolographic Analysis Laboratory, Institute of Rural Health, Poland ²Department of Pathophysiology, Medical University of Lublin, Poland
Headache
34	Efficacy and safety of 2 dose regimens of subcutaneous administration of fremanezumab versus placebo for the preventive treatment of episodic migraine E. Aycardi¹, M. Bigal¹, P. Yeung¹, T. Blankenbiller¹, M. Grozinski-Wolff¹, Y. Yang¹, Y. Ma¹, D. Dodick², S. Silberstein³ ¹Clinical, Teva Pharmaceutical Industries, USA ²Department of Neurology, Mayo Clinic, USA ³Neurology, Jefferson Headache Center, USA
35	ID-Migraine is useful to detect cluster headache as well as migraine S.J. Cho¹, P. W. Chung², B. K. Kim³, S. K. Kim⁴, M. J. Lee⁵, Y. Choi⁶, J. W. Park⁷, B. S. Kim⁸, K. Oh⁹, C. S. Chung⁵, T. J. Song¹⁰, J. Cho¹¹ ¹Neurology, Dongtan Sacred Heart Hospital, South Korea ²Neurology, Kangbuk Samsung Hospital, South Korea ³Neurology, Eulji University School of Medicine, South Korea ⁴Neurology, Gyeongsang National University Hospital, South Korea ⁵Neurology, Neuroscience Center, Samsung Medical Center, South Korea ⁶Neurology, Presbyterian Medical Center, South Korea ⁷Neurology, Uijeongbu St.Mary’s Hospital, South Korea ⁸Neurology, Bundang Jesaeng Hospital, South Korea ⁹Neurology, Korea University College of Medicine, South Korea ¹⁰Neurology, Ewha Womans University School of Medicine, South Korea ¹¹Cancer Education Center, Samsung Comprehensive Cancer Center, Samsung Medical Center, South Korea
36	Assessment of occupation in Korean cluster headache Y.J. Choi¹, S. J. Cho², M. J. Lee³, J.W. Park⁴, J. H. Sohn⁵, M. K. Chu⁶, H-S. Moon⁷, P.W. Chung⁷, B. K. Kim⁸, T. J. Song⁹, B. S. Kim¹⁰, K. Y. Park¹¹ ¹Department of Neurology, Presbyterian Medical Center, South Korea ²Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, South Korea ³Department of Neurology, Samsung Seoul Hospital, Sungkyunkwan University School of Medicine, South Korea ⁴Department of Neurology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, South Korea ⁵Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, South Korea ⁶Department of Neurology, Gangnam Sacred Heart Hospital, Hallym University College of Medicine, South Korea ⁷Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, South Korea ⁸Department of Neurology, Eulji University School of Medicine, South Korea ⁹Department of Neurology, Ewha Womans University School of Medicine, South Korea ¹⁰Department of Neurology, Bundang Jesaeng General Hospital, Daejin Medical Center, South Korea ¹¹Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, South Korea
37	A tailor-made suit rather than one size fits all: why triptans are not the best choice for first line migraine attack treatment E. Czapińska-Ciepiela Epilepsy and Migraine Treatment Centre, Poland
38	The impacts of migraine attacks on cognition in young Iranian chronic migraineurs in resting state H. Ebrahimi¹, M. M. Najaf Abadi¹, S. Allahdadian¹, J. M. Annoni², A. A. Najafinezhad¹, M. R. Asadolahian Sichani¹, B. Ansari³, M. Khodabakhsh¹ ¹Medical school, Islamic Azad University, NajafAbad branch,Esfahan,Iran, Iran ²Neurology Unit, Department of Medicine, Faculty of Sciences, University of Fribourg, Switzerland ³Medical science, Esfahan University, Iran
39	The positive impact of fremanezumab on work productivity and activity impairment in patients with chronic migraine S. Gandhi¹, T. Fitzgerald¹, P. Yeung¹, J. Cohen¹, R. Yang¹, E. Aycardi¹, R. Lipton² ¹HEOR/Clinical/Medical, Teva Pharmaceutical Industries, USA ²Neurology, Albert Einstein College of Medicine, USA
40	Glyceryl trinitrate (GTN)-induced headache is affected by priming of trigeminal system P. Gazerani¹, B. Cairns^1,2, H. Yassin¹, J. Yousefi¹, A. Sherzaman¹, B. Nedergaard³, S. Boldsen⁴ ¹Department of Health Science and Technology, Aalborg University, Denmark ²Faculty of Pharmaceutical Sciences, University of British Columbia, Canada ³CCBR Aalborg, Center for Clinical and Basic Research, Denmark ⁴Forskningens Hus, Aalborg University Hospital, Denmark
41	Episodic ataxia with intermittent headache, ataxia, and diplopia I. Gottlob¹, M. Thomas¹, C. Constantinescu², G. Maconachie¹ ¹Ophthalmology, University of Leicester, UK ²Neurology, University of Nottingham, UK
42	Comorbidities and risk factors in a prospective chronic migraine registry: study in a series of 723 patients A. Guerrero, M. Ruiz, M. I. Pedraza, A. Sierra, E. Martínez, J. López, A. Chavarría, B. Talavera, D. García-Azorín Headache Unit. Neurology Department, Hospital Clínico Universitario, Spain
43	Intracranial tumor as a challenge for multidisciplinary approach P. Halczuk, K. Rejdak Chair and Department of Neurology, Medical University of Lublin, Poland
44	Association between STX1A c.31-1811CT polymorphism and serotonin concentration in migraine patients M. Kowalska¹, I. Wieczorek², M. Prendecki¹, W. Świerczek², M. Kapelusiak-Pielok³, W. Kozubski³, J. Dorszewska¹ ¹Poznan University of Medical Sciences, Laboratory of Neurobiology, Department of Neurology, Poland ²Poznan University of Medical Sciences, Students Scientific Neurobiological Association, Poland ³Poznan University of Medical Sciences, Chair and Department of Neurology, Poland
45	Headache is the predictor of lacunar strokes: the data from the stroke registry sits-Kyrgyzstan I. Lutsenko¹, D. Nazhmudinova¹, U. Nurbekova² ¹Neurology, Kyrgyz State Medical Academy, Kyrgyzstan ²Neurology, The National Center of Maternity and Childhood Care, Kyrgyzstan
46	Influence of accompanying symptoms on chronization of migraine I. Maryenko, S. Likhachev, I. Pliashko Department of Neurology, Republican Research and Clinical Center of Neurology and Neurosurgery, Belarus
47	Medication overuse headache - prevalence, management and quality of life G. Mihailescu^1,2, R. Huber¹, A-D. Boangiu², C. Baetu², I. Buraga^1,2, S-M. Nica^1,2 ¹Neurology Department, University of Medicine and Pharmacy Carol Davila, Romania ²Neurology Department, Colentina Clinical Hospital, Romania
48	Clinical case of familial hemiplegic migraine E. Veevnik, S. Likhachev Scientific department of Neurology, Republican Research and Clinical Center of Neurology and Neurosurgery, Belarus
Multiple Sclerosis
49	Sexual dysfunction (SD) in multiple sclerosis (MS) population - incidence and management as it results from our experience C. Baetu¹, G.M. Bododea², G. Mihailescu¹, A-M. Enachi¹, R. Oana, I. Ionela, I. Buraga¹ ¹Neurology, Colentina Clinical Hospital, Romania ²Neurology, Ramnicu Valcea Emergency Hospital, Romania
50	Headache in patients with MS - causes and management - Colentina Clinical Hospital experience G.M. Bododea¹, C. Baetu², A. M. Enachi², I. Buraga² ¹Neurology, Ramnicu Valcea Emergency Hospital, Romania ²Neurology, Colentina Clinical Hospital, Romania
51	Characteristics of multiple sclerosis relapses and factors affecting relapses frequency in patients with immunomodulatory therapy M. Bozhenko Department of Neurology, Danylo Halytsky Lviv National Medical University, Ukraine
52	Evaluation of the long-term treatment effect of teriflunomide on cognitive outcomes and association with brain volume change: data from TEMSO and its extension study S. Cavalier⁷, T. Sprenger^1,2, M. P. Sormani³, J. S. Wolinsky⁴, J. Wuerfel⁵, K. Thangavelu⁶, M. Mandel⁸, L. Kappos⁹ ¹Department of Neurology, University Hospital Basel, Switzerland ²Department of Neurology, DKD HELIOS Klinik, Germany ³Department of Health Sciences, University of Genoa, Italy ⁴McGovern Medical School, UTHealth, USA ⁵Medical Image Analysis Center (MIAC AG), University of Basel, Switzerland ⁶Department of Biostatistics, Sanofi, USA ⁷MS Global Scientific Communications, Sanofi, USA ⁸Department of Neurology, Sanofi, USA ⁹Neurologic Clinic and Policlinik, University Hospital Basel, Switzerland
53	Neurofibromatosis (NF1) and multiple sclerosis (MS) - a rare association A.M. Enachi¹, C. Baetu¹, G. Mihailescu¹, I. Ionescu¹, R. Oana¹, M. G. Bododea², I. Buraga¹ ¹Neurology, Colentina Clinical Hospital, Romania ²Neurology, Ramnicu Valcea Emergency Hospital, Romania
54	Vaccines and multiple sclerosis: old dilemmas, new approaches E. Kurmaku^{1, 2}, G. Vyshka ^{1, 2}, J. Kruja ^{1, 2} ¹Faculty of Medicine, University of Medicine, Tirana, Albania ²Service of Neurology, UHC Mother Theresa, Tirana, Albania
55	The role of advanced glycation of proteins in the etiopathogenesis of multiple sclerosis B. Labuz-Roszak^2,4, B. Kumaszka^1,3, A. Damasiewicz-Bodzek¹, A. Nowak¹, K. Tyrpien-Golder¹ ¹Department of Chemistry, Medical University of Silesia in Katowice, Faculty of Medicine with Dentistry Division in Zabrze, Poland ²Department of Basic Medical Sciences, Faculty of Public Health, Medical University of Silesia, Poland ³Strzelce Opolskie, District Hospital, Poland ⁴Department of Neurological Rehabilitation, GCR Repty, Poland
56	Oligoclonal band multiple sclerosis presenting with sudden hearing loss I.C. Lupescu¹, I. G. Lupescu^2,4, A. O. Dulamea^1,3 ¹Neurology Department, Fundeni Clinical Institute, Romania ²Radiology and Medical Imaging Department, Fundeni Clinical Institute, Romania ³Neurology Department, Carol Davila University of Medicine and Pharmacy - Faculty of Dental Medicine, Romania ⁴Radiology and Medical Imaging Department, Carol Davila University of Medicine and Pharmacy - Faculty of Medicine, Romania
57	Validation of MS-TEQ in Albanian E. Rraklli^1,2, O. Çibuku^1,2, A. Tela^1,2, I. Buxhelaj^1,2, S. Grabova², P. Djamanti², A. Quka², J. Kruja^1,2 ¹Neuroscience, Faculty of Medicine, University of Medicine, Albania ²Neurology, UHC Mother Teresa, Albania
58	Rapid disease progression following initiation treatment with dimethyl fumarate in patient with neuromyelitis optica spectrum disorders (NMOSDS) J. Rudnicka-Czerwiec, M. Popiel, H. Bartosik-Psujek Klinika Neurologii z Pododdziałem Leczenia Udarów Mózgu, Kliniczny Szpital Wojewódzki nr 2, Poland
59	A case report of oligodendroglioma and multiple sclerosis: Occam’s razor or Hickam’s dictum? /h3 A. Shirani, G. Wu, A. Cross Department of Neurology, Washington University School of Medicine, USA
60	Does the nature of nutrition affect the development and course of relapsing-remitting multiple sclerosis (RRMS)? L. Sokolova, K. Potapova Neurology Department, Bogomolets National Medical University, Ukraine
61	Efficacy of a third course of alemtuzumab in patients with active relapsing-remitting multiple sclerosis who experienced disease activity after the initial two courses: pooled analysis of CARE-MS I and II P. Vermersch¹, A. Traboulsee², A. Boster³, A. Bass⁴, R. Berkovich⁵, G. Comi⁶, O. Fernández⁷, H. J. Kim⁸, V. Limmroth⁹, J. Lycke¹⁰, R. Macdonell¹¹, B. Sharrack¹², H. Wiendl¹³, T. Ziemssen¹⁴, M. Melanson¹⁵, N. Daizadeh¹⁵, B. Singer¹⁶ ¹Service de Neurologie Générale et Pathologie Neuro-Inflammatoire, University of Lille, France ²MS/NMO Clinic and Clinical Trials Research Group, University of British Columbia, Canada ³Clinical Neuroimmunology, OhioHealth Neurological Physicians, USA ⁴Department of Neurology, Neurology Center of San Antonio, USA ⁵Keck School of Medicine, University of Southern California, USA ⁶Department of Neurology, University Vita-Salute San Raffaele, Italy ⁷Department of Neurology, Fundación IMABIS Hospital Universitario Carlos Haya, Spain ⁸Research Institute, National Cancer Center, South Korea ⁹Klinik für Neurologie und Palliativmedizin, Kliniken Köln, Germany ¹⁰Department of Clinical Neuroscience, University of Gothenburg, Sweden ¹¹Department of Neuroscience and Mental Health, Austin Health and The Florey Institute, Australia ¹²Department of Neuroscience, Sheffield Teaching Hospitals NHS Foundation Trust, UK ¹³Department of Neurology, University of Münster, Germany ¹⁴Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Germany ¹⁵Sanofi Genzyme, Sanofi, USA ¹⁶MS Center for Innovations in Care, Missouri Baptist Medical Center, USA
62	Serum levels of inflammatory cytokines after supplementation of vitamin D in patient with multiple sclerosis (MS) treated by interferon – β (IFNβ) A. Walawska-Hrycek, E. Krzystanek Department of Neurology, Medical University of Silesia, School of Medicine in Katowice, Poland
63	Durable efficacy outcome improvements over 6 years in alemtuzumab-treated RRMS patients who relapsed between courses 1 and 2 (CARE-MS I) H. Wiendl¹, S. Broadley², O. Fernández³, M. Freedman⁴, G. Izquierdo⁵, J. Lycke⁶, C. Pozzilli⁷, B. Sharrack⁸, B. Singer⁹, B. Steingo¹⁰, P. Vermersch¹¹, S. Wray¹², B-V. Wijmeersch¹³, T. Ziemssen¹⁴, L. Chung¹⁵, N. Daizadeh¹⁵, K. Thangavelu¹⁵, A. Boster¹⁶ ¹Department of Neurology, University of Münster, Germany ²School of Medicine, Griffith University School, Gold Coast Campus, Australia ³Department of Neurology, Fundación IMABIS Hospital Universitario Carlos Haya, Spain ⁴Ottawa Hospital Research Institute, University of Ottawa, Canada ⁵Department of Neurology, Virgen Macarena University Hospital, Spain ⁶Department of Clinical Neuroscience, University of Gothenburg, Sweden ⁷Department of Neurology, University of Rome, Italy ⁸Department of Neuroscience, Sheffield Teaching Hospitals NHS Foundation Trust, UK ⁹MS Center for Innovations in Care, Missouri Baptist Medical Center, USA ¹⁰Department of Neurology, Fort Lauderdale Multiple Sclerosis Center, USA ¹¹Service de Neurologie Générale et Pathologie Neuro-Inflammatoire, University of Lille, France ¹²Department of Neurology, Hope Neurology, USA ¹³Rehabilitation and MS Centre Overpelt BIOMED, Hasselt University, Belgium ¹⁴Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Germany ¹⁵Sanofi Genzyme, Sanofi, USA ¹⁶Clinical Neuroimmunology, OhioHealth Neurological Physicians, USA
64	Slowing of cortical gray matter atrophy with teriflunomide is associated with delayed conversion to clinically definite MS R. Zivadinov^1,2, M-G. Dwyer¹, E. Carl¹, K. Thangavelu³, S. Cavalier⁴, N. Bergsland¹ ¹Buffalo Neuroimaging Analysis Center, University at Buffalo, USA ²Center for Biomedical Imaging at Clinical Translational Science Institute, University at Buffalo, USA ³Department of Biostatistics, Sanofi, USA ⁴MS Global Scientific Communications, Sanofi, USA
Neuroimmunology
65	Targeting key signaling factors as a way to control microglial activation and induction of neuroinflammation B. Badyra, A. Tejchman, M. Hereta, M. Majka Department of Transplantation, Medical College Jagiellonian University, Poland
66	Demyelinating disease during anti-tumor necrosis factor α therapy – case report B. Bielecki, M. Kowalska-Galecka, M. Pawelczyk, K. Turobos, S. Janiak, A. Glabinski Department of Neurology and Stroke, University Clinical Hospital - Military Medical Academy Memorial, Medical University of Lodz, Poland
67	Stiff person syndrome as initial manifestation of systemic lupus erythematosus: a case report D. Filimonov¹, S. Yevtushenko², L. Kardashevskaya³, D. Diuba², E. Marusichenko² ¹Department of Experimental Surgery, V.K. Gusak Institute of Urgent and Reparative Surgery, Ukraine ²Department of Reconstructive Angioneurology and Neurorehabilitation, V.K. Gusak Institute of Urgent and Reparative Surgery, Ukraine ³Department of Hematology, V.K. Gusak Institute of Urgent and Reparative Surgery, Ukraine
68	Haptenic diseases J. Grzeszczuk 1, Institute of Haptenology, Poland
69	Fungal infections: complication of immunosuppressive therapy of myasthenia gravis M. Makowska^1,2 ¹Neurology, Nordwest Krankenhaus, Germany ²Neurology, Nordwest Krankenhaus, Germany
70	Neuroinflammatory markers in dementia with Lewy bodies and dementia in Parkinson’s disease N. Mikhaylova¹, L. Androsova², I. Otman³, T. Klyushnik⁴ ¹Geriatric psychiatry department, Mental Health Research Centre, Russia ²Immunology laboratory, Mental Health Research Centre, Russia ³Immunology laboratory, Mental Health Research Centre, Russia ⁴Immunology laboratory, Mental Health Research Centre, Russia
71	Implication of autoantibodies against lactosylceramide in a neuroinflammatory disorder, EMRN T. Mutoh, S. Shima, Y. Niimi, Y. Mizutani, A. Ueda, S. Ito Neurology, Fujita Health University School of Medicine, Japan
72	Immune response against neural antigens and paraneoplastic neurological syndromes in endometrial cancer patients K. Poplawska-Domaszewicz¹, S. Michalak³, D. Szpurek², A. Paluch², S. Sajdak², W. Kozubski¹ ¹Department of Neurology Poznan University of Medical Sciences, Poznan University of Medical Sciences, Poland ²Department of Gynecological Surgery Poznan University of Medical Sciences, Poznan University of Medical Sciences, Poland ³Neuroimmunological Unit, Polish Academy of Sciences, Poznan, Poland, Department of Neurochemistry and Neuropathology Poznan University of Medical Sciences, Poznan, Poland, Poland
73	A case of localized variant of Guillain-Carré syndrome associated with IGM anti-β2-GPI antibodies H. Rhee¹, Y. Kwon², S. Kim¹, S. Yoon², K. Park², J. Lee² ¹Neurology, Kyung Hee University Hospital at Gangdong, South Korea ²Neurology, Kyung Hee University Hospital, South Korea
74	Olfactory deficits in mice with experimental autoimmune encepharomyelititis, a model of human multiple sclerosis T. Shin¹, J. Kim¹, Y. Choi¹, M. Ahn¹, K. Jung² ¹Department of Veterinary Medicine, Jeju National University, South Korea ²Immonoregulatory Materials Research Center, KRIBB, South Korea
Other
75	Ultrasonography may be more valuable to localize ulnar nerve entrapment without conduction block in electrodiangosis J.Y. An Department of Neurology, St. Vincent’s hospital, The Catholic University of Korea, South Korea
76	Polycythemia vera a potential cause of spinal cord infarction: a case report O. Çibuku^1,2, E. Rraklli^1,2, A. Kuqo², A. Quka², A. Tela^1,2, I. Buxhelaj^1,2, A. Rroji², J. Kruja^1,2 ¹Neuroscience, Faculty of Medicine, University of Medicine, Albania ²Neurology, UHC Mother Teresa, Albania
77	Angioblastoma in the cervical segment of the spinal cord in a 50-year old patient with peripheral symptoms - case report K. Gniadek-Olejniczak^1,2 ¹Klinika Rehabilitacji, Wojskowy Instytut Medyczny, Poland ²Klinika Rehabilitacji, Wojskowy Instytut Medyczny, Poland
78	Transverse myelitis as a first symptom of lupus erythematosus I. Ionescu, O. Rujan, A. Enachi, G. Mihailescu, C. Baetu, I. Buraga Neurology, Colentina Clinical Hospital, Romania
79	BDNF level in vascular depression and the therapeutic role of Actovegin L. Kruglov^1,2, M. Kumov³, M. Molodtsova³, I. Goloschapova³ ¹Department of Geriatric Psychiatry, National Medical Research Center of Psychiatry and Neurology named after V.M. Bekhterev, Russia ²Chair of Psychiatry and Neurology, St. Petersburg University, Russia ³Department of Geriatric Psychiatry, Psychiatric Hospital named after P.P. Kaschenko, Russia
80	A retrospective two-year analysis of the diagnosis of paraplegia made in the emergency room E. Kurmaku^1,2, G. Vyshka^1,2, J. Kruja^1,2 ¹Neuroscience, Faculty of Medicine, University of Medicine, Albania ²Neurology, UHC Mother Teresa, Albania
81	Serum lactate and pyruvate in relation to clinical severity rate in pediatric facial nerve neuropathy I. Liskevych, M. Pityk Department of Neurology and Neurosurgery, Ivano-Frankivsk National Medical University, Ukraine
82	Neurological aspects in a case of amyloidosis transthyretin type variant Glu54Gln D. Mirela^1,2,3,4,5, M. Draghici⁵ ¹Neurology, Valciu Crisanda, Romania ²Hematology, Andreea Jercan, Romania ³Hematology, Daniel Coriu, Romania ⁴Hematology, Badelita Sorina Nicoleta, Romania ⁵Hematology, Daniel Coriu, Romania
83	Posterior reversible encephalopathy syndrome in rapid progressive glomerulonephritis S.M. Noh Neurology, The Catholic University of Korea, St. Vincent’s Hospital, South Korea
84	Brain atrophy correlates with optic nerve atrophy in LHON with MS-like disease-Harding’s syndrome - case report I. Rościszewska-Żukowska, M. Dziki Department of Neurology, The Holy Family Specialist Hospital, Poland
85	Diagnostic pitfalls in Creutzfeldt-Jakob disease O. Rujan¹, I. Ionescu², A. Enachi², G. Mihailescu², C. Baetu², I. Buraga² ¹Neurology, Colentina Clinical Hospital, Romania ²Neurology, Colentina Clinical Hospital, Romania
86	Wernicke encephalopathy in a young man as a complication of Crohn’s disease - a case report M. Świtońska, R. Sokołowski, V. Palacz-Duda Stroke Intervention Treatment Center, Department of Neurology, University Hospital, No. 2, Poland
87	Prevalence of diabetes sensory neuropathy by a questionnaire interview in a cohort of Taiwanese diabetes patients C.H. Tseng¹, C.K. Chong², J.J. Sheu³, T.H. Wu¹, D. Wang⁴ ¹Department of Internal Medicine, National Taiwan University Hospital, Taiwan ²Department of Rehabilitation, Chong’s Physical Medicine and Rehabilitation Center, Taiwan ³Department of Neurology, Taipei Medical University Hospital, Taiwan ⁴Pfizer Innovative Health Medical, Pfizer Limited, Taiwan
88	Neuroimaging features of structural changes in the brain and their relationship with different forms of the cerebral palsy in children O. Yevtushenko¹, S. Yevtushenko², E. Fomicheva³, E. Savchenko⁴, D. Filimonov⁵ ¹Director, Regional Pediatric Neurorehabilitation Center, Ukraine ²Chief Researcher, Regional Pediatric Neurorehabilitation Center, Ukraine ³Department of Cerebral Palsy, Regional Pediatric Neurorehabilitation Center, Ukraine ⁴Department of Radiological Diagnostics, V.K. Gusak Institute of Urgent and Reparative Surgery, Ukraine ⁵Department of Experimental Surgery, V.K. Gusak Institute of Urgent and Reparative Surgery, Ukraine
89	Post-traumatic cervical dystonia in a patient with neurofibromatosis type 1 T. Yoon¹, J. Yun¹, J. Lee¹, S. Yoon¹ ¹Department of Neurology, Kyung Hee University Medical Center, South Korea
90	Changing vertical nystagmus in the opposite direction: is the transition from upbeat to downbeat nystagmus a diagnostic clue for Wernicke’s Encephalopathy? W.T. Yoon Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, South Korea
Parkinson's Disease and Other Movement Disorders
91	Frequency and associations of Tardive Dyskinesia in a cohort of patients with chronic mental disorders in North West Ireland D. Adamis, J. Tan, F. Saleem, B. McCafferty Psychiatry, Sligo Mental Health Services, Ireland
92	Parkinson’s disease: network analysis of publications' activity A. Buldyaev², F. Aleskerov^1,3, O. Khutorskaya³, A. Yamilov² ¹Faculty of Economic Sciences / Department of Mathematics, National Research University Higher School of Economics, Russia ²Faculty of Computer Science, National Research University Higher School of Economics, Russia ³Research Department, Institute of Control Sciences of Russian Academy of Sciences, Russia
93	Newly diagnosed extrapyramidal and movement disorders in Croatia throughout eleven years (2006-2016) L. Filipovic-Grcic, F. Derke School of Medicine, University of Zagreb, Croatia
94	27-hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons O. Ghribi Biomedical Sciences, The University Of North Dakota School of Medicine, USA
95	Metabolism of lipids in Parkinson’s disease V. Gryb, S. Genyk Neurology and Neurosurgery, Ivano-Frankivsk National Medical University, Ukraine
96	Changing the game for treating Parkinson`s disease dementia Y.J. Ho, A-C. Chen, C-H. Tai, P-F. Kao, C-Y. Shen, W-H. Wang, C-C. Kuo, M-A. Tikhonova, T-G. Amstislavskaya Department of Psychology, Chung Shan Medical University, Taiwan
97	Patient with Essential Palatal Tremor and coexistence bipolar disorder successfully treated with botulinum toxin injection; a case report W. Ibrahim, N. Merghany Neurology department, Kasralainy hospital, Faculty of Medicine, Cairo University, Egypt
98	Anodal transcranial direct current stimulation prevents methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurotoxicity as a in vivo mouse model of Parkinson’s disease through autophagy modulation W. Jang Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, South Korea
99	Can miglustat halt the progression of Niemann-Pick disease type C J. Kim Neurology, Dong-A University Hospital, South Korea
100	Fatigue in idiopathic Parkinson`s disease: clinical characteristics and risk factors S.M. Kim, Y. Yang, S. W. Ha, J.H.. Han, D.E. Kim Neurology, Veterans Health Service Medical Center, South Korea
101	A qualitative assessment of dynamic balance reactions in patients with Parkinson’s disease K. Krzysztoń, J. Stolarski, J. Kochanowski Department of Neurology of the Second Faculty of Medicine with the English Division and the Physiotherapy Division, Medical University of Warsaw, Poland
102	Autosomal dominant spinocerebellar ataxia type 40 caused by mutations in the CCDC88C gene - report of the first European family M. Leńska-Mieciek¹, A. Charzewska², D. Hoffman-Zacharska², U. Fiszer¹ ¹Department of Neurology and Epileptology, Centre of Postgraduate Medical Education, Poland ²Department of Medical Genetics, Institute of Mother and Child, Poland
103	Encephalitis lethargica syndrome: clinical features and management of two cases S. Lobzin, I. Kula Neurology, North-Western State medical University n.a. I.I. Mechnikov, Russia
104	Glucose transporter type 1 (GLUT-1) Deficiency Syndrome – delayed diagnosis and treatment: case report E. Naganska¹, P. Bogucki², D. Hoffman-Zacharska³, M. Jurek³, U. Fiszer² ¹Department of Neurology and Epileptology, Professor Witold Orlowski Independent Public Clinical Hospital, Warsaw, Poland ²Department of Neurology and Epileptology, Centre of Postgraduate Medical Education, Warsaw, Poland ³Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland, Poland
105	De novo ADCY5 mutation in patient who showed early onset dystonia and paroxysmal choreoathetosis in Korea E. Oh¹, D. Kim², J. Park³, C. Lee⁵, J. Youn⁴ ¹Neurology, Chungnam National University Hospital, South Korea ²Neurology, Dong-A university hospital, South Korea ³Neurology, Soonchunhyang University Hospital, South Korea ⁴Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea ⁵Health Sciences and Technology, Samsung Genome Institute, Samsung Medical Center, South Korea
106	Doctor, researcher or a friend? T. Rogalski Neurology, Self study, Poland
107	COPPADIS-2015: an ongoing global Parkinson’s disease project about disease progression with more than 700 patients included. Preliminary results of baseline evaluations D. Santos¹, S. Escalante², E. Cubo³, F. Carrillo⁴, J-C. Martínez Castrillo⁵, P. Sánchez Alonso⁶, M. Gemma A. Losada⁷, N. López Aríztegui⁸, M. Itziar Gastón⁹, J. Kulisevsky¹⁰, M. Menéndez González¹¹, M. Seijo¹², J. Ruíz Martínez¹³, C. Valero¹⁴, M. Kurtis¹⁵, B. Galeano¹⁶, O. De Fábregues-Boixar¹⁷, J. González Ardura¹⁸, C. Prieto¹⁹, P. Martínez Martín²⁰, COPPADIS Study Group²¹ ¹Neurology, Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Spain ²Neurology, Hospital de Tortosa Verge de la Cinta (HTVC), Spain ³Neurology, Complejo Asistencial Universitario de Burgos, Spain ⁴Neurology, Hospital Universitario de Canarias, San Cristóbal de la Laguna, Spain ⁵Neurology, Hospital Universitario Ramón y Cajal, Spain ⁶Neurology, Hospital Universitario Puerta de Hierro, Spain ⁷Neurology, Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Spain ⁸Neurology, Complejo Hospitalario de Toledo, Spain ⁹Neurology, Complejo Hospitalario de Navarra, Spain ¹⁰Neurology, Hospital de Sant Pau, Spain ¹¹Neurology, Hospital Universitario Central de Asturias, Spain ¹²Neurology, Complejo Hospitalario Universitario de Pontevedra (CHOP), Spain ¹³Neurology, Hospital Universitario Donostia, Spain ¹⁴Neurology, Hospital Arnau de Vilanova, Spain ¹⁵Neurology, Hospital Ruber Internacional, Spain ¹⁶Neurology, Hospital Universitario de Ceuta, Spain ¹⁷Neurology, Hospital Universitario Vall d´Hebron, Spain ¹⁸Neurology, Hospital Universitario Lucus Augusti (HULA), Spain ¹⁹Neurology, Hospital Rey Juan Carlos, Spain ²⁰Centro Nacional de Epidemiología y CIBERNED, Instituto de Salud Carlos III, Spain ²¹Neurology, Other Centres from Spain, Spain
108	Neuromodulatory role of subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD) patients S. Szlufik¹, A. Przybyszewski², K. Duszynska-Was¹, I. Laskowska-Levy³, J. Dutkiewicz¹, A. Drzewinska¹, P. Habela², T. Mandat⁴, D. Koziorowski¹ ¹Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Poland ²Department of Informatics, Polish Japanese Academy of Information Technology, Poland ³Department of Psychology, University of Finance and Management, Poland ⁴Department of Neurosurgery, Institute of Psychiatrics and Neurology, Poland
109	Levodopa: prescription errors in the use of antiparkinsonian drugs Y. Takeuchi^1,3, J. Valderrama^1,2, M. Molina³, S. Prada⁴, J. Orozco^1,2,3 ¹Neurología, Fundación Valle del Lili, Colombia ²Centro de Investigaciones Clínicas, Fundación Valle del Lili, Colombia ³Facultad de Ciencias de la Salud, Universidad Icesi, Colombia ⁴PROESA, Universidad Icesi, Colombia
110	Immobilization test as an assessment of the treatment effectiveness in patients with restless legs syndrome on the basis of diabetic polyneuropathy N. Tkachuk, V. Gryb Neurology, Ivano-Frankivsk national medical university, Ukraine
111	Ghrelin reduces A-type potassium channels in nigral dopaminergic neurons via PKC but not PKA pathway J. Xie, L. Shi, B. Xue Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders and State Key Disciplines: Physiology, Qingdao University, China
112	Lactoferrin shows protective effects in a MPTP-induced mouse model of Parkinson’s disease J. Xie, J. Wang, H. Liu, H. Wu Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders and State Key Disciplines: Physiology, Qingdao University, China
113	Comparison of gait parameters between drug-naïve patients with multiple system atrophy with predominant parkinsonism and Parkinson’s disease J.Y. Youn, J-W. Cho, J-S. Kim, B. Na Neurology, Samsung Medical Center, South Korea
Rehabilitation
114	Nucleo CMP forte in the treatment of patients with radiculopathy: clinical and neurophysiologic studies S. Huseynova Laboratory of Clinical Neurophysiology, Scientific Research Institute of Medical Rehabilitation, Azerbaijan
115	Protective effect of agomelatine on traumatic brain injury induced cognitive deficit in rats: possible role of neurotransmitters P. Kumar¹, T. Kaur² ¹Department Pharmaceutical Sciences and Technology, Maharaja Ranjit Singh Punjab Technical University, India ²Pharmacology, ISF College of Pharmacy, India
116	Cognitive interventions and cognitive training in adults with HIV: a state of the science D. Vance, P. Fazeli, S. Morrison, J. Cheatwood, C. Nicholson School of Nursing, University of Alabama at Birmingham, USA
Sleep
117	A case of restless legs syndrome in patient with neurogenic sciatic nerve tumor S. Cho¹, J. Lee², H. Rhee³, S. Yoon², K. Hwang², J. Lee² ¹Neurology, SM Christianity Hospital, South Korea ²Neurology, Kyung Hee University Hospital, South Korea ³Neurology, Kyung Hee University Hospital at Gangdong, South Korea
Stroke
118	Diagnostic of rare form of acute stroke (venous stroke) in early postpartum period N. Chemer, N. Ruda Stroke Unit, Department of Neurology, Kyiv Regional Clinical Hospital, Ukraine
119	Spinal cord infarction or acute myelitis? Fibrocartilaginous embolization as a rare cause of spinal cord infarction A. Damiza-Detmer¹, M. Pawełczyk², A. Głąbiński² ¹Department of Neurology and Stroke, University Clinical Hospital Military Memorial Medical Academy – Central Veteran ´s Hospital in Lodz, Poland;, Poland ²Department of Neurology and Stroke, Medical University of Lodz, Poland
120	Nuclear abnormalities as a manifestation of mitotic instability of vascular myocytes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) D. Dziewulska^1,2, E. Nycz³ ¹Neurology, Medical University of Warsaw, Poland ²Experimental and Clinical Neuropathology, Mossakowski Medical Research Center, PAS, Poland ³Neurology, Medical Center, Poland
121	Clinical correlates of post-stroke apathy V. Gerasymchuk Department of Neurology and Neurosurgery, Ivano-Frankivsk National Medical University, Ukraine
122	Insufficient physical activity among population of Azerbaijan K.H. Hasanov², R. Shiraliyeva¹, R. Aliyev¹, D. Aliyeva³ ¹Neurology and clinical neurophysiology, Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev, Azerbaijan ²Neurology 2, Republican Clinic Hospital, Azerbaijan ³Normal Physiology, Azerbaijan Medical University, Azerbaijan
123	Post-stroke care systems – comparison of organization, changes and tendencies in Poland and New Zealand K. Hennessey¹, D. Budzyna-Dawidowski¹, R. Czekaj² ¹Lekarski, English Division, Uniwersytet Medyczny im Piastów Śląskich we Wrocławiu, Poland ²Oddział Neurologiczny, Szpital im .Żeromskiego w Krakowie, Poland
124	Case of Hashimoto`s encephalopathy under mask of another diagnosis V. Hertsev, T. Muratova, O. Kolesnyk, O. Lebid, O. Varbanets, G. Perkova Neurological department, Odessa National Medical University, Ukraine
125	An unusual case of stroke in young adult after motor vehicle accident without evidence of dissection L. Jaffe², T. McIlvaine¹ ¹Internal Medicine, Tripler Army Medical Center, USA ²Neurology, Tripler Army Medical Center, USA
126	Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke D.H. Kim¹, E. Oh², H. Nah¹, J. Cha¹ ¹Department of Neurology, Dong-A University Hospital, South Korea ²Department of Neurology, Chungnam National University Hospital, South Korea
127	The number of endovascular thrombectomy attempt is related to clinical outcomes in large artery occlusion in patients with acute ischemic stroke E. Kim, J. Seo, H. Jung Neurology, Inje University Paik Hospital, South Korea
128	Anxiety traits as predictor of stroke in general population in Russia / Siberia: gender features. WHO program MONICA-Psychosocial study E. Krymov, I. Gagulin, E. Gromova, D. Panov, A. Gafarova, V. Gafarov Collaborative Laboratory of Cardiovascular Diseases Epidemiology, NIITP- branch Institute of Cytology and Genetics, Russia
129	Implication of calpain-mediated beta-secretase up-regulation for neurodegeneration in the postischemic basal ganglia H.B. Liang, Y. Minabe, T. Yamashima Department of Restorative Neurosurgery and Psychiatry, Kanazawa University, Japan
130	Carotid “web-like” stenosis as a complication of endarterectomy I. Mendes, T.B. Silvério, A.C. Ribeiro Neurology, Hospital Garcia de Orta, EPE, Portugal
131	Carotid stenosis cause cognitive decline M. Mijajlovic Cerebrovascular Disorders, Neurology Clinic, Clinical Center of Serbia and School of Medicine University of Belgrade, Serbia
132	Stent deployment as a treatment for stent retriever failure in acute ischemic stroke: an evidence-based case report Z.F. Nafisah¹, A.P. Permana² ¹Faculty of Medicine, Universitas Indonesia, Indonesia ²Neurosurgery Department, Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo National General Hospital, Indonesia
133	Homeotic genes expression profile of peripheral blood leukocytes in transient ischemic attacks and cerebral ischemic strokes K. Piasecka-Stryczynska¹, A. Malinska², M. Nowicki² ¹Neurology, Szpital im. Prof. S. T. Dąbrowskiego S.A., Poland ²Department of Histology and Embryology, Poznan University of Medical Sciences, Poland
134	Cerebral venous sinus thrombosis in pregnancy U. Rosinska¹, P. Wlodarczyk², M. Wiszniewska¹ ¹Neurology, Szpital Specjalistyczny w Pile im. Stanislawa Staszica, Poland ²Obstetrics and Gynecology, Szpital Specjalistyczny w Pile im. Stanislawa Staszica, Poland
135	Clinical case: how to treat venous stroke in women in early postpartum period? N. Ruda, N. Chemer Neurology, Kyiv Regional Hospital, Ukraine
136	Does the spleen play a role in acute neurological injuries? S. Savitz, F. Vahidy, A. Zha, J. Aronowski Institute for Stroke and Cerebrovascular Disease, UTHealth, USA
137	Search for the embolic source: a patient with two consecutive stroke episodes M. Tavsanli, C. Aktan, S. Ucler Neurology, Saglik Bilimleri University Okmeydani Education and Research Hospital, Turkey
138	Factors associated with concomitant asymptomatic intracranial artery stenosis in patients with atherothrombotic brain infarction attributable to intracranial artery stenotic lesion T. Uehara, K. Yoshida, H. Terasawa, H. Shimizu, Y. KIta Neurology, Hyogo Brain and Heart Center at Himeji, Japan
139	Mechanical thrombectomy for the posterior circulation stroke: analysis of outcomes and comparison to anterior circulation large vessel occlusion treatment M. Wiącek¹, A. Perenc¹, R. Kaczorowski¹, H. Bartosik-Psujek^1,2 ¹Department of Neurology, Clinical Regional Hospital No. 2, Poland ²Faculty of Medicine, University of Rzeszów, Poland
140	Repeated thrombectomy of middle cerebral artery J. Wojczal¹, P. Luchowski¹, M. Sojka², K. Pyra², S. Stachowicz¹, M. Górnik², K. Buraczyńska¹, J. Jaworski¹, K. Rejdak¹, Z. Stelmasiak¹, T. Jargiełło² ¹Dept. of Neurology, Medical University of Lublin, Poland ²Dept. of Interventional Radiology and Neuroradiology, Medical University of Lublin, Poland
141	Isolated choroid plexus infarction presenting as acute-onset Parkinsonism S. Yoon¹, E. Kim², H. Rhee³, J. Lee¹ ¹Neurology, Kyung Hee University Hospital, South Korea ²Radiology, Kyung Hee University Hospital, South Korea ³Neurology, Kyung Hee University Hospital at Gangdong, South Korea
142	Predictive values of neutrophil to lymphocyte and platelet to lymphocyte ratios in outcomes of patients with stroke N. Zmouli^1,3, M. Benyoub^2,3, D. Badsi^2,3, W. Tidjane^2,3, H. Toumi^1,3, M. Hammadi^2,3 ¹Pharmacy, FACULTY OF MEDECINE, Algeria ²Medecine, FACULTY OF MEDECINE, Algeria ³University hospital establishment, EHUO, Algeria
Wilson’s Disease
143	Gastroscopy findings in Wilson’s disease patients before and during D-penicillamine or zinc sulphate treatment M. Antczak-Kowalska¹, A. Przybyłkowski², T. Litwin¹, A. Członkowska¹ ¹Second Department of Neurology, Institute of Psychiatry and Neurology, Poland ²Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Poland
144	Different brain pathology in neurological and hepatic forms of Wilson disease depicted by quantitative MRI M. Dezortova¹, M. Hajek¹, V. Herynek¹, L. Kotackova², D. Zahorakova³, R. Bruha⁴, Z. Marecek⁵, P. Dusek⁶ ¹MR-Unit, Dept. Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Czech Republic ²Institute of Clinical Biochemistry and Laboratory Diagnostics, Charles University and General University Hospital in Prague, Czech Republic ³Dept. Pediatrics and Adolescent Medicine, Charles University and General University Hospital in Prague, Czech Republic ⁴4th Dept. Internal Medicine, Charles University and General University Hospital in Prague, Czech Republic ⁵KlinMed, Prague, Czech Republic ⁶Dept. Neurology and Center of Clinical Neuroscience, Charles University and General University Hospital in Prague, Czech Republic
145	Clinical and laboratory characteristics of different stages of Wilson’s disease M. Karaseva¹, T. Fedorova², E. Panina³, S. Lobzin³, A Nekrasova³ ¹Neurology, International Medical Center “SOGAZ”, Russia ²Neurology, Saint-Petersburg Clinical Hospital of the Russian Academy of Sciences, Russia ³Neurology, North-Western State Medical University named after I.I. Mechnikov, Russia
146	Pseudodominant inheritance of Wilson disease – case report A. Kraśniej-Dębkowska, A. Członkowska 2^nd Department of Neurology, Institute of Psychiatry and Neurology, Poland
147	Transcranial sonography in Wilson’s disease patients M. Skowronska, T. Litwin, K. Dziezyc, I. Kurkowska-Jastrzebska, A. Czlonkowska 2^nd Department of Neurology, Institute of Psychiatry and Neurology, Poland